On the role of FAN1 in Fanconi anemia

Blood

Volumn 120, Issue 1, 2012, Pages 86-89

  Trujillo, Juan P ^a,b   Mina, Leonardo B ^a,b   Pujol, Roser ^a,b   Bogliolo, Massimo ^a,b   Andrieux, Joris ^c   Holder, Muriel ^c   Schuster, Beatrice ^d   Schindler, Detlev ^d   Surrallés, Jordi ^a,b  

^a UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

^b INSTITUTO DE SALUD CARLOS III   (Spain)

^c LILLE UNIVERSITY HOSPITAL   (France)

^d UNIVERSITY OF WÜRZBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

FA NUCLEASE 1; FANCONI ANEMIA PROTEIN; MITOMYCIN C; UNCLASSIFIED DRUG;

ARTICLE; CASE REPORT; CELL SURVIVAL; CHILD; CHROMOSOME 15Q; CHROMOSOME DELETION; CHROMOSOME FRAGILITY; CLINICAL FEATURE; DNA CROSS LINKING; DNA FLANKING REGION; FANCONI ANEMIA; G2 PHASE CELL CYCLE CHECKPOINT; GENE; GENE AMPLIFICATION; GENE DELETION; HOMOZYGOSITY; HUMAN; INFANT; POLYMERASE CHAIN REACTION; PRESCHOOL CHILD; PRIORITY JOURNAL; SCHOOL CHILD; WESTERN BLOTTING;

EID: 84863579727     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2012-04-420604     Document Type: Article

References (24)

1. Kutler DI, Singh B, Satagopan J, et al. A 20-year perspective on the International Fanconi Anemia Registry (IFAR). Blood. 2003;101(4):1249-1256. (Pubitemid 36182492)
2. Rosenberg PS, Tamary H, Alter BP. How high are carrier frequencies of rare recessive syndromes? Contemporary estimates for Fanconi anemia in the United States and Israel. Am J Med Genet A. 2011;155A(8):1877-1883.
3. Callén E, Casado JA, Tischkowitz MD, et al. A common founder mutation in FANCA underlies the world's highest prevalence of Fanconi anemia in Gypsy families from Spain. Blood. 2005;105(5): 1946-1949. (Pubitemid 40731776)
4. Wang W. Emergence of a DNA-damage response network consisting of Fanconi anaemia and BRCA proteins. Nat Rev Genet. 2007;8(10): 735-748. (Pubitemid 47429206)
5. Meindl A, Hellebrand H, Wiek C, et al. Germline mutations in breast and ovarian cancer pedigrees establish RAD51C as a human cancer susceptibility gene. Nat Genet. 2010;42(5):410-414.
6. Meetei AR, Medhurst AL, Ling C, et al. A human ortholog of archaeal DNA repair protein Hef is defective in Fanconi anemia complementation group M. Nat Genet. 2005;37(9):958-963. (Pubitemid 43086152)
7. Kim Y, Lach FP, Desetty R, Hanenberg H, Auerbach AD, Smogorzewska A. Mutations of the SLX4 gene in Fanconi anemia. Nat Genet. 2011; 43(2):142-146.
8. Kratz K, Schopf B, Kaden S, et al. Deficiency of FANCD2-associated nuclease KIAA1018/FAN1 sensitizes cells to interstrand crosslinking agents. Cell. 2010;142(1):77-88.
9. Liu T, Ghosal G, Yuan J, Chen J, Huang J. FAN1 acts with FANCI-FANCD2 to promote DNA interstrand cross-link repair. Science. 2010; 329(5992):693-696.
10. MacKay C, Declais AC, Lundin C, et al. Identification of KIAA1018/FAN1, a DNA repair nuclease recruited to DNA damage by monoubiquitinated FANCD2. Cell. 2010;142(1):65-76.
11. Smogorzewska A, Desetty R, Saito TT, et al. A genetic screen identifies FAN1, a Fanconi anemia-associated nuclease necessary for DNA interstrand crosslink repair. Mol Cell. 2010;39(1): 36-47.
12. Masurel-Paulet A, Andrieux J, Callier P, et al. Delineation of 15q13.3 microdeletions. Clin Genet. 2010;78(2):149-161.
13. Lepichon JB, Bittel DC, Graf WD, Yu S. A 15q13.3 homozygous microdeletion associated with a severe neurodevelopmental disorder suggests putative functions of the TRPM1, CHRNA7, and other homozygously deleted genes. Am J Med Genet A. 2010;152A(5):1300-1304.
14. Bogliolo M, Lyakhovich A, Callen E, et al. Histone H2AX and Fanconi anemia FANCD2 function in the same pathway to maintain chromosome stability. EMBO J. 2007;26(5):1340-1351. (Pubitemid 46398698)
15. Kalb R, Neveling K, Hoehn H, et al. Hypomorphic mutations in the gene encoding a key Fanconi anemia protein, FANCD2, sustain a significant group of FA-D2 patients with severe phenotype. Am J Hum Genet. 2007;80(5):895-910. (Pubitemid 46668458)
16. Raya A, Rodriguez-Piza I, Guenechea G, et al. Disease-corrected haematopoietic progenitors from Fanconi anaemia induced pluripotent stem cells. Nature. 2009;460(7251):53-59.
17. Castella M, Pujol R, Callen E, et al. Chromosome fragility in patients with Fanconi anaemia: diagnostic implications and clinical impact. J Med Genet. 2011;48(4):242-250.
18. Castella M, Pujol R, Callen E, et al. Origin, functional role, and clinical impact of Fanconi anemia FANCA mutations. Blood. 2011;117(14):3759- 3769.
19. Liao J, DeWard SJ, Madan-Khetarpal S, Surti U, Hu J. A small homozygous microdeletion of 15q13.3 including the CHRNA7 gene in a girl with a spectrum of severe neurodevelopmental features. Am J Med Genet A. 2011;155A(11):2795-2800.
20. Antonio Casado J, Callen E, Jacome A, et al. A comprehensive strategy for the subtyping of patients with Fanconi anaemia: conclusions from the Spanish Fanconi Anemia Research Network. J Med Genet. 2007;44(4):241-249. (Pubitemid 46596437)
21. Auerbach AD. Diagnosis of Fanconi anemia by diepoxybutane analysis. Curr Protoc Hum Genet. 2003;Chapter 8:Unit 8.7.
22. Ceccaldi R, Briot D, Larghero J, et al. Spontaneous abrogation of the GDNA damage checkpoint has clinical benefits but promotes leukemogenesis in Fanconi anemia patients. J Clin Invest. 2011;121(1):184-194.
23. Yoshikiyo K, Kratz K, Hirota K, et al. KIAA1018/ FAN1 nuclease protects cells against genomic instability induced by interstrand cross-linking agents. Proc Natl Acad Sci U S A. 2010;107(50): 21553-21557.
24. O'Driscoll M, Jeggo PA. The role of the DNA damage response pathways in brain development and microcephaly: insight from human disorders. DNA Repair (Amst). 2008;7(7):1039-1050.